Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate and Ixekizumab Subcutaneous

• Generic Name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide
• Dosage Forms: n.a.
• Other Brand Names: Symtuza

Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate is a four-drug combination of darunavir (DRV), an HIV-1 protease inhibitor, cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 NRTIs, and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no prior antiretroviral treatment history or who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir.

• Generic Name: ixekizumab
• Dosage Forms: n.a.
• Other Brand Names:

  Taltz Autoinjector, Taltz Prefilled Syringe

Ixekizumab injection is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatments.

Ixekizumab injection is also used alone or together with other medicines (eg, methotrexate) to treat active psoriatic arthritis.

Ixekizumab is available only with your doctor's prescription.